The "Multi-Bagger" Portfolio: An Update

Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022 - DOWN 73% vs. 2021 - but perhaps some of them will bounce back with major - dare I say "multi-bagger" - returns in 2023.

Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022 - Down 73% vs. 2021 - but there's a chance some of them will bounce back with major - dare I say "multi-bagger" - returns in 2023. MunKNEE.com tracks the performance of the largest Canadian cannabis LPs, American cannabis MSOs, psychedelic drug stocks and plant-based food stocks in four separate indexes on a weekly basis and the munKNEE "Multi-bagger" Portfolio consists of the 12 smallest of the stocks (market capitalizations between $50M and $399M - an average of only $136M) in those indexes. The munKNEE "Rags-to-Riches" Portfolio, in comparison, consists of the remaining 14 stocks in the same four indices but with market capitalizations between $400M and $3.0B - average of $968M.

Here's an update on how the various categories in the Portfolio, and their constituents, have performed in the past 2 weeks of March so far (MTD) and year-to-date (YTD).

  1. American Cannabis MSO constituents:
    • Acreage (ACRDF/ACRHF): Down 5.5% MTD; Up 14.2% YTD;
    • Ascend (AAWH): Up 3.4% MTD; Down 6.9% YTD;
    • Ayr (AYRWF): Down 31.9% MTD; Down 36.4% YTD;
    • Columbia Care (CCHWF): Down 6.6% MTD; Down 24.0% YTD;
    • Jushi (JUSHF): Down 10.9% MTD; Down 23.0% YTD; and
    • Planet 13 (PLNHF): Down 4.5% MTD; Up 17.9% YTD.
      • Down 9.4% MTD; Down 9.5% YTD.
    • For comparison purposes, the AdvisorShares Pure U.S. Cannabis ETF (MSOS) is Down 3.4% MTD and Down 10.0% YTD.
  2. Canadian Cannabis LP constituents:
    • Aurora (ACB): Down 13.1% MTD; Down 18.0% YTD;; and
    • Organigram (OGI): Down 20.3% MTD; Down 19.2% YTD.
      • Down 9.8% MTD; Down 13.3% YTD
    • For comparison purposes, the Global X Cannabis ETF (POTX) is Down 13.3% MTD; Down 16.2% YTD.
  3. Psychedelic Drug Stock constituents:
    • Cybin (CYBN): Down 25.0% MTD; Up 34.5% YTD;
    • Mind Medicine (MNMD): Down 22.0% MTD; Up 33.0% YTD; and 
    • Seelos Therapeutics (SEEL): Down 16.5% MTD; Up 1.5% YTD.
      • Down 21.5% MTD; Up 26.6% YTD.
    • For comparison purposes, the AdvisorShares Psychedelics ETF (PSIL) is Down 15.5% MTD; Up 3.3% YTD.
  4. Plant-Based Food Stock constituent:
    • Tattooed Chef (TTCF): Up 8.7% MTD; Up 8.9% YTD.
      • Up 8.7% MTD; Up 8.9% YTD.
    • No comparable plant-based food stock ETFs

Grand Total: The munKNEE "Multi-bagger" Portfolio is Up 0.6% MTD and  Down 8.6% YTD

In comparison, our munKNEE "Rags-to-Riches" Portfolio is Down 8.6% MTD and Down 3.7% YTD while the S&P 500 which is Down 1.4% MTD and Up 2.0% YTD.


More By This Author:

Planet 13: Eight Analysts Forecast An Average Upside Of 94% Within 12 Months
Cresco Labs: Across-The-Board Negative Q4 Financial Metrics  
Aurora Cannabis: 14 Analysts Only See An 80% Upside In Next Year

Disclosure:

None

Visit  munKNEE.com and register to receive our free Market Intelligence Report newsletter (sample here).

STOCKS IN THIS ARTICLE

Comments